New York State Teachers Retirement System Has $20.23 Million Stock Position in STERIS plc $STE

New York State Teachers Retirement System grew its position in STERIS plc (NYSE:STE) by 2.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 81,749 shares of the medical equipment provider’s stock after acquiring an additional 2,142 shares during the quarter. New York State Teachers Retirement System owned 0.08% of STERIS worth $20,228,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Jones Financial Companies Lllp boosted its stake in STERIS by 46.1% during the first quarter. Jones Financial Companies Lllp now owns 1,106 shares of the medical equipment provider’s stock worth $251,000 after buying an additional 349 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of STERIS by 32.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 242,732 shares of the medical equipment provider’s stock valued at $55,015,000 after buying an additional 59,264 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of STERIS by 16.1% during the 1st quarter. Empowered Funds LLC now owns 2,303 shares of the medical equipment provider’s stock worth $522,000 after acquiring an additional 319 shares during the period. Woodline Partners LP boosted its position in shares of STERIS by 40.0% during the 1st quarter. Woodline Partners LP now owns 8,300 shares of the medical equipment provider’s stock valued at $1,881,000 after acquiring an additional 2,372 shares in the last quarter. Finally, Jane Street Group LLC boosted its position in shares of STERIS by 38.9% during the 1st quarter. Jane Street Group LLC now owns 20,716 shares of the medical equipment provider’s stock valued at $4,695,000 after acquiring an additional 5,803 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors.

STERIS Stock Performance

NYSE:STE opened at $260.61 on Tuesday. The stock has a market capitalization of $25.58 billion, a P/E ratio of 37.44 and a beta of 1.03. The company has a current ratio of 2.37, a quick ratio of 1.63 and a debt-to-equity ratio of 0.27. STERIS plc has a 1 year low of $204.28 and a 1 year high of $268.60. The firm has a 50 day moving average of $257.99 and a 200-day moving average of $246.01.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period in the prior year, the company earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, sell-side analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Tuesday, November 18th were paid a $0.63 dividend. The ex-dividend date was Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS’s dividend payout ratio (DPR) is 36.21%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research report on Friday. Seven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $273.50.

Insider Activity

In other STERIS news, VP Renato Tamaro sold 5,036 shares of the stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the sale, the vice president owned 5,695 shares of the company’s stock, valued at $1,466,747.25. This represents a 46.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Julia Madsen sold 5,008 shares of the firm’s stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the completion of the sale, the vice president owned 10,710 shares of the company’s stock, valued at $2,806,020. The trade was a 31.86% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 25,044 shares of company stock worth $6,586,218. 1.07% of the stock is owned by corporate insiders.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.